In this lecture stream on Rheuma TV, Dr. S. Shankar presents on “CS DMARDS in Rheumatoid Arthritis: DMARDs in presence of Comorbidities.” The session examines the prevalence and global burden of multimorbidity in patients with rheumatoid arthritis (RA), drawing from Global Burden of Disease (GBD) study data regarding age- and sex-specific comorbidity rates. Dr. Shankar provides clinical insights into selecting, monitoring, and adjusting conventional synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs)—including Methotrexate, Leflunomide, Sulfasalazine, and Hydroxychloroquine—in RA patients presenting with co-existing renal, hepatic, pulmonary, cardiovascular, or infectious conditions.
